Viagra is about to get a lot cheaper
It's blue times for the little blue pill.
Drug companies will get their first shot at introducing generic alternatives to Viagra next week, when drugmaker Pfizer Inc.'s patent-protected monopoly expires Monday. But Viagra's parent company isn't going down without a fight, The Associated Press reports: Pfizer is launching its own generic version of the famed erectile dysfunction pill in order to minimize its losses when other generics hit the market.
Jim Sage, the president of U.S. brands for Pfizer Essential Health, says, "We believe the story for Viagra isn't done. It's just going to be a new chapter."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
That new chapter, apparently, involves Pfizer introducing a subscription service for Viagra. AP writes that beginning next year, Pfizer will "offer two new discount programs and increase its copayment card discounts," while "uninsured men can get brand-name Viagra half off through an innovative online home delivery program." Additionally, patients with insurance may be able to receive a month's worth of pills "for as little as a $20 copayment."
Customers who wish to remain unsubscribed will see benefits, too: Starting Monday, a generic version of the impotence pill will be available for half of the usual $65-a-pill retail price. AP also notes that next summer, when more generic impotence pills have flooded the market, prices could drop by as much as 90 percent.
Dr. Nachum Katlowitz, a urologist at New York Staten Island University Hospital, predicted to AP: "When generic Viagra comes out, [patients] will be very happy."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kelly O'Meara Morales is a staff writer at The Week. He graduated from Sarah Lawrence College and studied Middle Eastern history and nonfiction writing amongst other esoteric subjects. When not compulsively checking Twitter, he writes and records music, subsists on tacos, and watches basketball.
-
Donald Trump’s week in Asia: can he shift power away from China?Today's Big Question US president’s whirlwind week of diplomacy aims to bolster economic ties and de-escalate trade war with China
-
The Icelandic women’s strike 50 years onIn The Spotlight The nation is ‘still no paradise’ for women, say campaigners
-
Mall World: why are people dreaming about a shopping centre?Under The Radar Thousands of strangers are dreaming about the same thing and no one sure why
-
Warner Bros. explores sale amid Paramount bidsSpeed Read The media giant, home to HBO and DC Studios, has received interest from multiple buying parties
-
Gold tops $4K per ounce, signaling financial uneaseSpeed Read Investors are worried about President Donald Trump’s trade war
-
Electronic Arts to go private in record $55B dealspeed read The video game giant is behind ‘The Sims’ and ‘Madden NFL’
-
New York court tosses Trump's $500M fraud fineSpeed Read A divided appeals court threw out a hefty penalty against President Trump for fraudulently inflating his wealth
-
Trump said to seek government stake in IntelSpeed Read The president and Intel CEO Lip-Bu Tan reportedly discussed the proposal at a recent meeting
-
US to take 15% cut of AI chip sales to ChinaSpeed Read Nvidia and AMD will pay the Trump administration 15% of their revenue from selling artificial intelligence chips to China
-
NFL gets ESPN stake in deal with DisneySpeed Read The deal gives the NFL a 10% stake in Disney's ESPN sports empire and gives ESPN ownership of NFL Network
-
Samsung to make Tesla chips in $16.5B dealSpeed Read Tesla has signed a deal to get its next-generation chips from Samsung
